Page 1093 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1093

2      References


                   29. Davies HD, McGeer A, Schwartz B, et al. Invasive group A   distinguishing necrotizing fasciitis from other soft tissue infec-
                      streptococcal infections in Ontario, Canada.  N Engl J Med.   tions. Crit Care Med. 2004;32:1535-1541.
                      1996;335:547-554.                                   39. Barry W,  Hudgins  L, Donta  ST,  Pesanti EL. Intravenous
                   30. Green RJ, Dafoe DC, Raffin TA. Necrotizing fasciitis.  Chest.   immunoglobulin therapy for toxic shock syndrome.  JAMA.
                      1996;110:219-229.                                      1992;267:3315-3316.
                   31. Wong CO, Wang YS. The diagnosis of necrotizing fasciitis. Curr     40. Kaul R, McGeer A, Norrby-Teglund A, et al. Intravenous
                      Opinion Infect Dis. 2005;18:101-106.                   immunoglobulin therapy for streptococcal toxic shock syn-
                   32. Roberts DS. Synergistic mechanisms in certain mixed infections   drome—a comparative observational study.  Clin Infect Dis.
                      (editorial). J Infect Dis. 1969;120:720.               1999;28:800-807.
                   33. Brook I, Frazier EH. Clinical and microbiologic features of nec-    41. Crum NF, Wallace MR. Group B streptococcal necrotizing fas-
                      rotizing fasciitis. J Clin Microbiol. 1995;33:2382-2387.  ciitis and toxic shock-like syndrome: a case report and review of
                                                                             the literature. Scand J Infect Dis. 2003;35:878-881.
                   34. Czymek R, Hildebrand P, Kleemann M, et al. New insights into
                      the epidemiology and etiology of Fournier’s gangrene: a review     42. Pessa ME, Howard RJ. Necrotizing fasciitis. Surg Gynecol Obstet.
                      of 33 patients. Infection. 2009;37:306-312.            1985;161:357-361.
                   35. Stamenkovic I, Lew DP. Early recognition of potentially fatal     43. Ebright JR, Pieper B. Skin and soft tissue infection in injection
                      necrotizing fasciitis. N Engl J Med. 1984;310:1689-1693.  drug users. Infect Dis Clin North Am. 2002;16:697-712.
                   36. Majeski J,  Majeski E.  Necrotizing fasciitis:  improved  survival     44. Pannaraj PS, Hulten KG, Gonzalez BE, Mason EO Jr, Kaplan SL.
                      with early recognition by tissue biopsy and aggressive surgical   Infective pyomyositis and myositis in children in the era
                      treatment. South Med J. 1997;90:1065-1068.             of   community-acquired, methicillin-resistant  Staphylococcus
                                                                             aureus infection. Clin Infect Dis. October 15, 2006;43(8):953-960.
                   37. Phan HH, Cocanour CS. Necrotizing soft tissue infections in the
                      intensive care unit. Crit Care Med. 2010;38(suppl 9):S460-S468.    45. George ME, Rueth NM, Skarda DE, et al. Hyperbaric oxygen
                                                                             does not improve outcome in patients with necrotizing soft
                   38. Wong CH, Khin LW, Heng KS, et al. The LRINEC (Laboratory     tissue infection. Surg Infect (Larchmt). 2009;10:21-28.
                      Risk Indicator for Necrotizing Fasciitis) score: a tool for




























































            Section05-O-ref.indd   2                                                                                   1/20/2015   4:51:24 PM
   1088   1089   1090   1091   1092   1093   1094   1095   1096   1097   1098